U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Science & Research
  3. About Science & Research at FDA
  4. FDA Grand Rounds
  5. FDA Grand Rounds - Acute Pain Management/Patient Experience Study in Diverse Populations - 10/10/2024
  1. FDA Grand Rounds

Webcast | Virtual

Event Title
FDA Grand Rounds - Acute Pain Management/Patient Experience Study in Diverse Populations
October 10, 2024

Date:
October 10, 2024
Time:
12:00 PM - 1:00 PM ET
Image
FDA Grand Rounds

Speaker

Mitra Ahadpour, M.D., D.A.B.M.

Mitra Ahadpour, M.D., D.A.B.M.
Deputy Director, Office of Translational Sciences
Center for Drug Evaluation & Research (CDER)
U.S. Food and Drug Administration (FDA)

About the Speaker

Dr. Mitra Ahadpour is the Principal Deputy Director of FDA’s Office of Translational Sciences. She is a Board-certified, Addiction Medicine Physician who leads scientific collaboration and innovation efforts in drug regulatory review across CDER. She previously directed the Division of Pharmacologic Therapies at SAMHSA (Substance Abuse and Mental Health Services Administration) and led the accreditation and certification of opioid treatment programs and health care provider training on safe opioid-prescribing. In private practice, she helped make Montgomery County and Maryland smoke free. She received the HHS 2015 Hubert H. Humphrey Award for Service to America and 2016 HHS Ignite Accelerator Award for creating and implementing the national Rapid Opioid Alert and Response Project, the framework for ODMAP (Overdose Mapping and Application Program).
Speaker 

Speaker

Molly Jeffery Ph.D.
Associate Professor of Emergency Medicine, Robert D. and Patricia E. Kern Honored Investigator in the Science of Health Care Delivery, Mayo Clinic

About the Speaker

Molly Jeffery Ph.D.

Molly M. Jeffery, Ph.D., co-director of the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI), is a health economist and health services researcher at Mayo Clinic, where she is Robert D. and Patricia E. Kern Center Honored Investigator in the Science of Health Care Delivery and an Associate Professor of Emergency Medicine.  Much of Dr. Jeffery's work involves using large databases of administrative data, including health insurance claims and electronic health records, to generate insight into the use of prescription opioids in the United States, as well as to better understand emergency department use for vulnerable patient populations.

About the Presentation

This seminar will provide a rationale and overview of the Acute Pain Pathways (APP) study, a prospective cohort study conducted in collaboration with the FDA to better understand pain management and pain control among individuals experiencing acute pain for various common diagnoses. Preliminary results will also be shared, including insights into patients’ pain trajectories, use of opioids to manage acute pain, and disposal patterns after pain is resolved.

Learning Objectives

  1. Describe recent trends in opioid use in the United States over the past decade, including settings of care.
  2. Discuss the rationale for and results of the Acute Pain Pathways (APP) study, a prospective cohort study that recruited a diverse cohort of patients experiencing acute pain seeking care in rural and urban settings across the United States, including outpatient clinics, emergency departments, dental clinics and hospitals, using a novel, decentralized design that leveraged a patient-centered digital health record for data collection.

To Register

FDA employees MUST register in BOTH the following: 

Non-FDA employees must register in:

  • ZOOM REGISTRATION *Once you have registered in ZOOM, you will receive a confirmation email with the webcast URL.

After Zoom webcast registration, you will receive a link via email to access the live webinar. You must log in with the username and password created when you registered.  Please pre-register at least two days before the event to ensure you receive the access link and outlook invitation for the session. We will discuss applications for this analysis and share finding from completed work.

For technical assistance please contact: Isaac.Miller@fda.hhs.gov

Event Materials

Activity Outline - Continuing Education

Back to Top